Ichihashi 等人 比较 TASC-II C/D 和 TASC-II A/B之间初始支撑架治疗的长期结果。文章显示 TASC-II CD（9%）并发症发生率显著高于 TASC-II（3%），但累积开通率两组间没有显著性差异。  Cumulative primary patency rates not statistically significant
1. Ichihashi et al. Long-term outcomes for systematic primary stent placement in complex iliac artery occlusive disease classified according to TASC-II. J Vasc Surg 2011 |